Home › Funds › Crosspoint Capital Strategies, LLC › MRNA

Crosspoint Capital Strategies, LLC position in MRNA

MODERNA INC · Health Care

Crosspoint Capital Strategies, LLC reported holding 20,355 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 3.77% of its reported portfolio and ranking #7 among its reported holdings. Crosspoint Capital Strategies, LLC first reported this position in Q3 2026.

Latest position (Q3 2026)20.36K sh
Reported value held$3.92M
Portfolio Weight3.77%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Crosspoint Capital Strategies, LLC's MRNA position evolved

Crosspoint Capital Strategies, LLC first disclosed a stake in MRNA in Q3 2026 at 20,355 shares (US$3.9M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 20.36K $3.92M New

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 42 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Crosspoint Capital Strategies, LLC held MRNA?

Crosspoint Capital Strategies, LLC has disclosed MRNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Crosspoint Capital Strategies, LLC's current position in MRNA?

As of Q3 2026, Crosspoint Capital Strategies, LLC holds 20.36K shares of MRNA (MODERNA INC), valued at $3.92M, representing 3.77% of its reported portfolio and ranking #7.

Has Crosspoint Capital Strategies, LLC been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Crosspoint Capital Strategies, LLC newly opened its position in MRNA.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.